{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:33:47Z","timestamp":1785897227352,"version":"3.56.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n The COVID-19 pandemic may serve as a natural experiment, with pandemic-associated changes in the epidemiology of Kawasaki disease (KD) potentially informing understanding of KD pathogenesis.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To assess long-term KD incidence across 50 years and to examine pandemic-associated changes in KD epidemiology across age groups.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cohort study was a descriptive epidemiologic analysis of data from the Japanese Nationwide Survey of Kawasaki Disease conducted from 2023 to 2024, along with 50 years of historical data. Data were included from patients with KD in the current 2023-2024 survey (n\u2009=\u200929\u202f841) and historical and current survey data from 1975 through 2024 (n\u2009=\u2009467\u202f456) for trend analysis.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Annual KD incidence overall and stratified by 3 age groups: infants (&amp;lt;1 year), 1 to 4 years, and 5 to 9 years.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The current survey registered 15\u202f032 and 14\u202f809 patients with KD in 2023 and 2024, respectively (overall, 57.3% male; median [IQR] age, 2 [1-4] years). Across the 50-year study period, despite the population under 5 years of age declining in Japan by 61.6%, KD incidence rates increased 16.1-fold. Across the COVID-19 pandemic period, patient numbers reached a nadir of 10\u202f333 in 2022, then rebounded to 15\u202f032 cases (45.5% increase) in 2023. Notably, decline and rebound patterns differed by age. Indexed incidence rates (using 2017 as a baseline of 100) demonstrated that patients 5 to 9 years of age had the largest decline (nadir of 54.2 in 2021, 45.8% below baseline) and the largest rebound (134.8 in 2024, 34.8% above baseline). In contrast, patients younger than 1 year showed the smallest decline (nadir of 73) and incidence rates did not return to baseline levels. When comparing the magnitude of rebound in KD incidence, a distinct age-dependent dose-response pattern was observed: 26.1% for infants, 38.9% for patients aged 1 year, 42.7% for patients aged 2 years, 85.8% for patients aged 3 years, 105.3% for patients aged 4 years, and 166.7% for patients aged 5 to 9 years.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this nationwide cohort study of KD in Japan, KD incidence rebounded after the relaxation of COVID-19 pandemic-related restrictions, with age-dependent patterns. Nonpharmaceutical interventions (eg, mask-wearing) during the pandemic may explain the greater rebound pattern observed in older children; however, the minimal changes in infants suggest different exposure pathways to potential KD triggers. These findings support an age-stratified approach to KD pathogenesis research, distinguishing infants from older children.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.26910","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:00:29Z","timestamp":1785855629000},"page":"e2626910","source":"Crossref","is-referenced-by-count":1,"title":["Epidemiology of Kawasaki Disease After the COVID-19 Pandemic in Japan 2023-2024"],"prefix":"10.1001","volume":"9","author":[{"given":"Ryusuke","family":"Ae","sequence":"first","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Kosami","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Masuda","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kato","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Kohro","sequence":"additional","affiliation":[{"name":"Data Science Center, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Seki","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Shibata","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan"},{"name":"Department of Electrical and Computer Engineering, National Institute of Technology, Gifu College, Motosu, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanari","family":"Kuwabara","sequence":"additional","affiliation":[{"name":"Division of Public Health, Center for Community Medicine, Jichi Medical University, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"issue":"3","key":"zoi260740r1","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children.","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"issue":"3","key":"zoi260740r2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1542\/peds.54.3.271","article-title":"A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.","volume":"54","author":"Kawasaki","year":"1974","journal-title":"Pediatrics"},{"issue":"23","key":"zoi260740r3","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","article-title":"Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association.","volume":"150","author":"Jone","year":"2024","journal-title":"Circulation"},{"issue":"8411","key":"zoi260740r4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease.","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"issue":"23","key":"zoi260740r5","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1056\/NEJM199106063242305","article-title":"A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome.","volume":"324","author":"Newburger","year":"1991","journal-title":"N Engl J Med"},{"issue":"9826","key":"zoi260740r6","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial.","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"issue":"10","key":"zoi260740r7","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/archdischild-2023-325639","article-title":"Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.","volume":"108","author":"Miyata","year":"2023","journal-title":"Arch Dis Child"},{"issue":"10176","key":"zoi260740r8","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0140-6736(18)32003-8","article-title":"Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial.","volume":"393","author":"Hamada","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"zoi260740r9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2018-3341","article-title":"Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis.","volume":"143","author":"Dionne","year":"2019","journal-title":"Pediatrics"},{"issue":"17","key":"zoi260740r10","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015308","article-title":"Corticosteroids added to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in high-risk patients with Kawasaki disease.","volume":"9","author":"Ae","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"zoi260740r11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI176938","article-title":"The etiologies of Kawasaki disease.","volume":"134","author":"Burns","year":"2024","journal-title":"J Clin Invest"},{"issue":"6","key":"zoi260740r12","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/jpids\/piab013","article-title":"The impact of social distancing for COVID-19 upon diagnosis of Kawasaki disease.","volume":"10","author":"Shulman","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"2","key":"zoi260740r13","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapediatrics.2020.5052","article-title":"Assessment of 135?794 pediatric patients tested for severe acute respiratory syndrome coronavirus 2 across the United States.","volume":"175","author":"Bailey","year":"2021","journal-title":"JAMA Pediatr"},{"issue":"25","key":"zoi260740r14","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.121.054785","article-title":"Reduction in Kawasaki disease after nonpharmaceutical interventions in the COVID-19 era: a nationwide observational study in Korea.","volume":"143","author":"Kang","year":"2021","journal-title":"Circulation"},{"issue":"12","key":"zoi260740r15","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamapediatrics.2022.3756","article-title":"Incidence of Kawasaki disease before and after the COVID-19 pandemic in Japan: results of the 26th nationwide survey, 2019 to 2020.","volume":"176","author":"Ae","year":"2022","journal-title":"JAMA Pediatr"},{"issue":"5","key":"zoi260740r16","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1017\/S104795112500191X","article-title":"Global incidence of Kawasaki disease: a systematic review.","volume":"35","author":"Kang","year":"2025","journal-title":"Cardiol Young"},{"issue":"1","key":"zoi260740r17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/INF.0000000000004095","article-title":"Kawasaki disease before and during the COVID-19 pandemic: a nationwide population-based study in the United States.","volume":"43","author":"Sakai-Bizmark","year":"2024","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"zoi260740r18","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1017\/S104795112510098X","article-title":"Sustained reduction in Kawasaki disease during the post-acute phase of the coronavirus disease 2019 pandemic: a follow-up study in Shiga, Japan.","volume":"35","author":"Hoshino","year":"2025","journal-title":"Cardiol Young"},{"key":"zoi260740r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.114251","article-title":"Resurgence of Kawasaki disease following relaxation of coronavirus disease 2019 pandemic restrictions in Japan.","volume":"275","author":"Nakata","year":"2024","journal-title":"J Pediatr"},{"issue":"6","key":"zoi260740r20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00431-025-06211-8","article-title":"Kawasaki disease in the pre- and post-COVID-19 era: shifts in patterns and outcomes from a multi-center study.","volume":"184","author":"Alfalasi","year":"2025","journal-title":"Eur J Pediatr"},{"key":"zoi260740r21","doi-asserted-by":"publisher","DOI":"10.2188\/jea.JE20250490","article-title":"Big data analyses using health care records can reveal epidemiologic features of Kawasaki disease in Japan: a study based on the national database of health insurance claims.","author":"Kobayashi","journal-title":"J Epidemiol"},{"key":"zoi260740r22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jpeds.2020.05.034","article-title":"Epidemiology, treatments, and cardiac complications in patients with Kawasaki disease: the nationwide survey in Japan, 2017-2018.","volume":"225","author":"Ae","year":"2020","journal-title":"J Pediatr"},{"issue":"1","key":"zoi260740r23","doi-asserted-by":"publisher","DOI":"10.1111\/ped.70007","article-title":"Epidemiology of Kawasaki disease in Japan in 2021-2022: results of the 27th nationwide survey.","volume":"67","author":"Nakamura","year":"2025","journal-title":"Pediatr Int"},{"issue":"10","key":"zoi260740r25","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1111\/ped.14326","article-title":"Revision of diagnostic guidelines for Kawasaki disease (6th revised edition).","volume":"62","author":"Kobayashi","year":"2020","journal-title":"Pediatr Int"},{"issue":"6","key":"zoi260740r26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.005378","article-title":"Predicting coronary artery aneurysms in Kawasaki disease at a North American center: an assessment of baseline z scores.","volume":"6","author":"Son","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"zoi260740r27","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCULATIONAHA.107.690875","article-title":"Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements.","volume":"116","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"issue":"8","key":"zoi260740r28","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","article-title":"JCS\/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease.","volume":"84","author":"Fukazawa","year":"2020","journal-title":"Circ J"},{"issue":"2","key":"zoi260740r29","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s00246-009-9599-7","article-title":"Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease.","volume":"31","author":"Manlhiot","year":"2010","journal-title":"Pediatr Cardiol"},{"issue":"2","key":"zoi260740r30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/S0022-3476(98)70229-X","article-title":"Coronary artery dimensions may be misclassified as normal in Kawasaki disease.","volume":"133","author":"de Zorzi","year":"1998","journal-title":"J Pediatr"},{"issue":"1","key":"zoi260740r32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S1473-3099(22)00525-4","article-title":"Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study.","volume":"23","author":"Bardsley","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"zoi260740r33","doi-asserted-by":"publisher","DOI":"10.2196\/68058","article-title":"Shifts in influenza and respiratory syncytial virus infection patterns in Korea after the COVID-19 pandemic resulting from immunity debt: retrospective observational study.","volume":"11","author":"Park","year":"2025","journal-title":"JMIR Public Health Surveill"},{"issue":"10","key":"zoi260740r34","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.70629","article-title":"Longitudinal RSV antibody trends in Thai children (0-8 years): association with seasonal outbreak patterns and potential immunity debt during the COVID-19 pandemic.","volume":"97","author":"Pasittungkul","year":"2025","journal-title":"J Med Virol"},{"issue":"7","key":"zoi260740r35","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1097\/INF.0000000000004314","article-title":"Respiratory syncytial virus bronchiolitis before and after COVID-19 pandemic: has the immunity debt been paid off?","volume":"43","author":"Nenna","year":"2024","journal-title":"Pediatr Infect Dis J"},{"key":"zoi260740r36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2025.108278","article-title":"Pathogen-specific immunity debt in children after prolonged nonpharmaceutical interventions: a cross-sectional study in China.","volume":"163","author":"Li","year":"2026","journal-title":"Int J Infect Dis"},{"key":"zoi260740r37","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jpeds.2021.11.061","article-title":"European Pediatric Societies call for an implementation of regular vaccination programs to contrast the immunity debt associated to coronavirus disease-2019 pandemic in children.","volume":"242","author":"Cohen","year":"2022","journal-title":"J Pediatr"},{"issue":"2","key":"zoi260740r38","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2022.12.003","article-title":"Immune debt: recrudescence of disease and confirmation of a contested concept.","volume":"53","author":"Cohen","year":"2023","journal-title":"Infect Dis Now"},{"issue":"6","key":"zoi260740r39","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/cid\/ciae493","article-title":"Cycles of susceptibility: immunity debt explains altered infectious disease dynamics post-pandemic.","volume":"81","author":"Munro","year":"2026","journal-title":"Clin Infect Dis"},{"key":"zoi260740r40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2024.114420","article-title":"Surge of pediatric respiratory tract infections after the COVID-19 pandemic and the concept of \u201cimmune debt\u201d.","volume":"284","author":"Lenglart","year":"2025","journal-title":"J Pediatr"},{"key":"zoi260740r41","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fped.2018.00374","article-title":"The epidemiology and pathogenesis of Kawasaki disease.","volume":"6","author":"Rowley","year":"2018","journal-title":"Front Pediatr"},{"key":"zoi260740r42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jpeds.2021.07.053","article-title":"Kawasaki disease and pediatric infectious diseases during the coronavirus disease 2019 pandemic.","volume":"239","author":"Ae","year":"2021","journal-title":"J Pediatr"},{"issue":"14-15","key":"zoi260740r43","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/S0264-410X(98)00108-X","article-title":"Maternal immunization against viral disease.","volume":"16","author":"Englund","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"zoi260740r44","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.55001","article-title":"Age-dependent variations in Kawasaki disease incidence in Japan.","volume":"7","author":"DeHaan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"zoi260740r45","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101791","article-title":"Kawasaki disease and outdoor environmental stressors: a scoping review.","volume":"66","author":"Madaniyazi","year":"2026","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"zoi260740r46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00246-022-03008-6","article-title":"Differences in sensitivity between the Japanese and z score criteria for detecting coronary artery abnormalities resulting from Kawasaki disease.","volume":"44","author":"Ae","year":"2023","journal-title":"Pediatr Cardiol"},{"key":"zoi260740r24","unstructured":"REDCap (Research Electronic Data Capture). Accessed January 25, 2026. https:\/\/project-redcap.org\/"},{"key":"zoi260740r31","unstructured":"Statistics of Japan. e-Stat: Portal Site for Japanese Government Statistics. Accessed January 25, 2026. https:\/\/www.e-stat.go.jp\/en"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852423\/ae_2026_oi_260740_1785249922.55346.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:00:31Z","timestamp":1785855631000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.26910","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}